Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 5 of 5 clinical reviews.
A clinician-focused guide to retatrutide dosing considerations for Hispanic and Latino patients, covering pharmacogenomics, metabolic phenotype differences, trial subgroup data, and practical titration guidance reviewed by the HealthRX.com medical team.
Read clinical reviewEvidence review of retatrutide efficacy in Black and African ancestry populations, covering Phase 2 subgroup data, pharmacogenomic factors, and clinical dosing considerations.
Read clinical reviewEvidence review of retatrutide efficacy in East Asian populations, including pharmacogenomic differences in CYP2C19/CYP2D6, lower BMI obesity thresholds, and limited subgroup data from the phase 2 trial.
Read clinical reviewHow retatrutide safety and tolerability differ in East Asian populations. Covers pharmacogenomic variants, BMI threshold adjustments, GI side effects, and clinical trial subgroup data.
Read clinical reviewEvidence review of retatrutide efficacy data in Hispanic and Latino populations, including phase 2 subgroup analysis, pharmacogenomic variants, and clinical dosing considerations.
Read clinical review